Tsveta Milanova

Tsveta Milanova

Chief Commercial OfficeratAgios Pharmaceuticals· In proxies 2021–2024

Pay in FY2024-34% from the year before · Agios Pharmaceuticals stock +47.6% the same year

Tsveta Milanova was paid $2.5M in FY2024 (Dec), down 34%. Agios Pharmaceuticals stock rose 47.6% that year.

Pay$100 in the stock at the end of FY20 → $76
Pay is from the Summary Compensation Table of each Agios Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Agios PharmaceuticalsPublic company · 5 yr
    • Chief Commercial Officer2021 – Present · 5 yrStock in role -16%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?